Navigation Links
Positive Phase 2b Results with Sarilumab in Rheumatoid Arthritis to be Presented as a Late-Breaking Poster at the 2011 American College of Rheumatology Annual Meeting
Date:10/27/2011

TARRYTOWN, N.Y., Oct. 27, 2011 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that detailed clinical data from the positive Phase 2b portion of the seamless Phase 2/3 MOBILITY trial of sarilumab (REGN88/SAR153191) in rheumatoid arthritis (RA) will be presented at a late-breaking poster session at the upcoming American College of Rheumatology (ACR) Annual Scientific Meeting, which will take place from November 5-9 in Chicago. Sarilumab is a novel, high-affinity, subcutaneously administered, fully-human antibody targeting the interleukin-6 receptor (IL-6R)

The poster will be presented on Tuesday, November 8 from 9 AM to 6 PM EST. The abstract, titled "Sarilumab for the Treatment of Moderate-to-Severe Rheumatoid Arthritis: Results of a Phase 2, Randomized, Double-Blind, Placebo-Controlled, International Study," is available on the ACR website at: http://acr.confex.com/acr/2011/webprogram/Paper24502.html.

About SarilumabSarilumab (REGN88/ SAR153191) is the first fully human monoclonal antibody directed against the alpha subunit of the IL-6 receptor complex (IL-6R Alpha).  Sarilumab is a high affinity, subcutaneously delivered, specific inhibitor of IL-6 signaling.  It blocks the binding of IL-6 to its receptor and interrupts the resultant cytokine-mediated inflammatory signaling cascade. Sarilumab was developed using Regeneron's VelocImmune® antibody technology.  

About the MOBILITY trialThe MOBILITY trial is a randomized, double-blind, placebo-controlled, multicenter, two-part, dose ranging Phase 2b and confirmatory Phase 3 study with an operationally seamless design, evaluating efficacy and safety of sarilumab in combination with methotrexate (MTX) in patients with active RA who are inadequate responders to MTX therapy.  

Th
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe
2. Halozyme Announces Positive Results from Roches Subcutaneous Herceptin Phase 3 Trial
3. Hydrocodone and Oxycodones Lead U.S. General Workforce Positives, Outranked Only by Marijuana, According to Quest Diagnostics Drug Testing Index™
4. Hepatitis C Phase 2A Trial Positive Results
5. Daval International Announces Positive Phase II Results for AIMSPRO® as a Monotherapy in Established Diffuse Cutaneous Systemic Sclerosis (Scleroderma)
6. Echo Therapeutics Announces Positive Results of Clinical Trial of Its Symphony® Continuous Glucose Monitoring System
7. NVA237 Filed in Europe and Positive Phase III Data at European Respiratory Society Congress
8. Update: OncoSec Announces Positive Results From Head & Neck and Breast Cancer Trials
9. Ampio Announces Positive Results From 12-Week Open Label Extension Study of Zertane™ in Patients With Premature Ejaculation.
10. ALIMTA Receives Positive Opinion From CHMP as Continuation Maintenance Therapy for Deadly Form of Lung Cancer
11. Clermont Pharmaceuticals Reports Positive Phase III Results for Drug to Treat Glaucoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015  The investigational ... to alleviate certain menopause symptoms, such as hot flashes, ... Journal of Women,s Health .[i] "Current ... S- equol for menopausal vasomotor symptoms and possibly additional ... safety of S- equol, physicians and health care ...
(Date:3/30/2015)... 2015 Research and Markets ... of the "Urological Catheters - Global ... offering. This report analyzes the ... Units and US$ Thousands by the following ... Peritoneal Catheters), and Urinary Catheters (Foley Catheters, ...
(Date:3/30/2015)... Mar. 26, 2015 Research and Markets ... of the "Marine Biotechnology - Global Strategic ... Annual estimates and forecasts are provided for ... historic analysis is provided for these markets. Market ... secondary research. This report analyzes the ...
Breaking Medicine Technology:New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 2New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 3New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 4New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 5New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 6Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 2Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 3Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 4Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 5Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 6Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 7Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 2Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 3Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 4Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 5Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 6Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 7
... Kendle (Nasdaq: KNDL ), a leading, ... awards of $152.1 million for the fourth quarter of ... 2009. Gross book-to-bill improved 25 percent sequentially from the ... quarter. Net book-to-bill for the quarter was 1.3 as ...
... Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX ) today ... by anesthesiologists in a growing number of hospitals and surgery ... Caldolor became the first injectable product approved by the FDA ... in adults. Designed primarily for use in the hospital setting, ...
Cached Medicine Technology:Kendle Announces Fourth Quarter and Full-Year 2010 Results 2Kendle Announces Fourth Quarter and Full-Year 2010 Results 3Kendle Announces Fourth Quarter and Full-Year 2010 Results 4Kendle Announces Fourth Quarter and Full-Year 2010 Results 5Kendle Announces Fourth Quarter and Full-Year 2010 Results 6Kendle Announces Fourth Quarter and Full-Year 2010 Results 7Kendle Announces Fourth Quarter and Full-Year 2010 Results 8Anesthesiologists Use Caldolor® To Provide Preemptive Pain Control for Surgical Patients at U.S. Medical Centers 2Anesthesiologists Use Caldolor® To Provide Preemptive Pain Control for Surgical Patients at U.S. Medical Centers 3Anesthesiologists Use Caldolor® To Provide Preemptive Pain Control for Surgical Patients at U.S. Medical Centers 4Anesthesiologists Use Caldolor® To Provide Preemptive Pain Control for Surgical Patients at U.S. Medical Centers 5
(Date:3/30/2015)... March 30, 2015 Foundations Recovery Network, ... announce the start of its 41st national conference by ... McGonigal, and former Congressman Patrick J. Kennedy as keynote ... being held in San Diego, CA, March 30 - ... national conference brings together leading experts specializing in the ...
(Date:3/30/2015)... Falls Church, VA (PRWEB) March 30, 2015 ... aseptic fill sites and flexible biological manufacturing plants. This ... trends in the business. , This has forced facilities ... lifespan. , The existing facilities have been forced ... have undergone a change of ownership. , Most of ...
(Date:3/30/2015)... 2015 Good Shepherd Children’s Home announces 53rd ... in Murfreesboro provides a Christian-based home, the children learn biblical ... his special plan for their life. , A day ... begins as, one-by-one, the children begin to awake and prepare ... alarm continues to buzz. Sleepily, she crawls out of ...
(Date:3/30/2015)... KIND LED’s suite of LED grow lights ... 2015. The excellent value and product features of the KIND ... position in the race for the best LED grow light ... suite of grow lights is the 12 band perfect ... (PAR) wavelengths that plants are most likely to use during ...
(Date:3/30/2015)... Dr. Jeff Farmer now offers mini dental implants ... is placed into the bone, usually without surgery, and the ... into place. For those having trouble with dentures or partials ... solution. Thousands of patients around the world now enjoy secure ... is all made possible by mini dental implants that are ...
Breaking Medicine News(10 mins):Health News:Foundations Recovery Network Kicks Off Its 41st National Conference Specializing in the Treatment of Substance Abuse and Behavioral Health 2Health News:FDAnews Announces: Aging Aseptic and Biological Manufacturing Facilities: Design and Renovation for Compliance Webinar, April 16, 2015 2Health News:FDAnews Announces: Aging Aseptic and Biological Manufacturing Facilities: Design and Renovation for Compliance Webinar, April 16, 2015 3Health News:Good Shepherd Children’s Home Announces 53rd Year of Providing a Safe-Haven for Children in Need 2Health News:Best LED Grow Lights of 2015 Are Being Led By KIND LED 2Health News:Dr. Jeffrey Farmer A Murfreesboro Dentist Announces New High Tech Dentistry 2
... dangerous environments, females looking for a mate run great ... the Smithsonian Tropical Research Institute in Panama present a ... issue of the Public Library of Science. The researchers ... helps them avoid their predators as they sequentially visit ...
... Amidst rising incidence of tuberculosis in Britain, senior doctors ... be screened for the disease. ,The ... Africa. ,The Observer reported Sunday that two ... that public health officials were failing to come to ...
... intervals in the music of many human cultures is rooted ... according to researchers at the Duke University Center for Cognitive ... sound right to our ears because of the way our ... said Dale Purves, the George Barth Geller Professor for Research ...
... Pakistani authorities have intensified monitoring of over 800 poultry farms ... five poultry farms there, an official said Saturday. ... in three farms May 22 and in two other farms ... state media reported, quoting Livestock Commissioner R.H Usmani. ...
... papers selected for publication in the August 2007 issue ... that become pregnant before they have achieved their full ... nourishment for their fetuses to develop without physical deficits. ... managing pregnancies of adolescent human females, who, in increasing ...
... team of scientists has discovered the secret behind inflorescence, ... branching structures. , ,Using mathematical models ... the evolutionary processes that work together to create inflorescences ... ,"This is a unifying theory that provides an explanation ...
Cached Medicine News:Health News:Scientists Report New Take on Sexual Signaling 2Health News:Essential Tones of Music Rooted in Human Speech 2Health News:Essential Tones of Music Rooted in Human Speech 3Health News:Sheep Offer Model for Undernourishment in Pregnant Teen Girls 2
Steroid eluting pacemaker leads...
... family of temporary sensing and pacing leads. ... in temporary pacing leads and improved upon ... use and less traumatic to heart tissue. ... Pacing Lead is designed for temporary atrial ...
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....
Medicine Products: